ASA
ASA is a pharmaceutical drug with 21 clinical trials. Currently 1 active trials ongoing. Historical success rate of 82.4%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
6
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.4%
14 of 17 finished
17.6%
3 ended early
1
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS)
Effects of Edoxaban on Platelet Aggregation
Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients
The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV
Clinical Trials (21)
Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS)
Effects of Edoxaban on Platelet Aggregation
Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients
The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV
Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults.
Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma
Outpatient Liquid Aspirin (OLA)
Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.
Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population
Platelet Sub-study of the TWILIGHT Trial
Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)
Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate
Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets
The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man
Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately
Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately
A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin
Bleeding Time Study With AZD6482, Clopidogrel and ASA
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 21